Tang Capital Management’s Dianthus Therapeutics DNTH Stock Holding History
Bought
Maintained
Sold
Other funds holding DNTH
Tang Capital Management's DNTH Position: Q3 2026 in Review
Tang Capital Management held its Dianthus Therapeutics (DNTH) position steady in Q3 2026 at 264,692 shares worth $23.3M. The position accounts for 1.07% of the portfolio, ranked #23.
Tang Capital Management first reported a position in DNTH in Q1 2023 and has held it in 15 quarters since. The position peaked at $25.8M in Q2 2026. 275 funds tracked by Wall St. Rank hold DNTH as of Q3 2026.
- Tang Capital Management held 264,692 shares of Dianthus Therapeutics worth $23.3M as of Q3 2026.
- Tang Capital Management left its Dianthus Therapeutics share count unchanged in Q3 2026.
- Dianthus Therapeutics made up 1.07% of Tang Capital Management's portfolio in Q3 2026, its #23 holding.
- Tang Capital Management first reported a position in Dianthus Therapeutics in Q1 2023 and has held it in 15 quarters since.
- Tang Capital Management's Dianthus Therapeutics position peaked at $25.8M in Q2 2026.
- 275 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q3 2026.
Based on Tang Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.